*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Homology Modeling and Drug Designing of Tumor Necrosis Factor14 Involved in Rheumatoid Arthritis

Author: CHITTEPU OBULA REDDY, KURAPATI RAJAGOPAL
Abstract: Tumor Necrosis Factor is an essential protein involved in Rheumatoid arthritis. In current research, the crystal structure of 2ZPX is used as an example to build a three-dimensional model of STAT4 using Modeller software. The final prototype is developed using techniques based on molecular mechanics and dynamics, and it is then checked for accuracy using Procheck and Verify 3D graph programs. According to the results, it was found that hydrocortison1 forms a hydrogen bond with TNF14 and observed to be more dominant inhibitor than other drugs, and it. We also infer that the TNF14 domain's MET3, ARG4, and THR5 are three significant binding residues based on our docking studies. Hydrogen bonding interactions account for a large part of the complex's stability. Our findings may prove useful in future experiments.
Keyword: Modeling, Reumatoid arthritis, Tumor Necrosis Factor, docking studies.
DOI: https://doi.org/10.31838/ijpr/2021.13.03.059
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free